MENA 2024 Recordings-Focus on Diabetes Related Retinopathy & Neuropathy

Video Transcription

Video Summary

The speaker addresses the challenges and advancements in diagnosing and treating diabetic neuropathy and retinopathy. They emphasize the ease of diagnosing retinopathy through digital retinal imaging and the application of AI for screening. However, neuropathy remains underdiagnosed due to the dependence on inadequate tests like monofilament. The speaker advocates for early detection of neuropathy to prevent severe complications like amputations. They introduce corneal confocal microscopy as a promising method for early neuropathy diagnosis. AI's role in both neuropathy and retinopathy screening is highlighted for its accuracy and potential to revolutionize diagnostics. The speaker also discusses treatment advancements, noting the benefits of GLP-1 therapies and SGLT2 inhibitors in managing neuropathy and retinopathy. Additionally, they emphasize lifestyle changes and the potential of phenofibrate for improving neuropathy and retinopathy outcomes. The importance of implementing comprehensive screening programs, similar to those for retinopathy, is underscored to enhance early detection and management of these diabetic complications.

Keywords

diabetic neuropathy

retinopathy

AI screening

corneal confocal microscopy

GLP-1 therapies

SGLT2 inhibitors